HTRA1 and neoplasm: On the basis of our data, we propose a model whereby LOX activates the secreted protease HTRA1, which inhibits TGFβ1 signalling, causing increased expression of the EGF-like domain containing protein MATN2, which then enhances EGFR signalling to drive tumour growth and metastasis (Fig. 8).